L. Perségol

493 total citations
14 papers, 409 citations indexed

About

L. Perségol is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Surgery. According to data from OpenAlex, L. Perségol has authored 14 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Clinical Biochemistry and 5 papers in Surgery. Recurrent topics in L. Perségol's work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Paraoxonase enzyme and polymorphisms (4 papers) and Antioxidant Activity and Oxidative Stress (4 papers). L. Perségol is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Paraoxonase enzyme and polymorphisms (4 papers) and Antioxidant Activity and Oxidative Stress (4 papers). L. Perségol collaborates with scholars based in France and Australia. L. Perségol's co-authors include Philippe Gambert, Bruno Vergès, Laurence Duvillard, Laurent Lagrost, Anne Athias, Matthieu Foissac, Christian Lallemant, Michel Farnier, Ginette Bessède and Catherine Desrumaux and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Analytical Biochemistry.

In The Last Decade

L. Perségol

13 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Perségol France 10 240 190 113 77 64 14 409
Mark S. Borja United States 14 197 0.8× 145 0.8× 151 1.3× 77 1.0× 29 0.5× 18 469
Valérie Guyard‐Dangremont France 8 267 1.1× 251 1.3× 144 1.3× 62 0.8× 32 0.5× 8 494
G. J. Miller United Kingdom 5 298 1.2× 264 1.4× 98 0.9× 125 1.6× 22 0.3× 6 505
Eva Xepapadaki Greece 12 131 0.5× 107 0.6× 81 0.7× 54 0.7× 19 0.3× 19 339
Shiyin Long China 12 132 0.6× 143 0.8× 97 0.9× 76 1.0× 18 0.3× 25 374
Gert-Jan Botma Netherlands 6 233 1.0× 267 1.4× 86 0.8× 95 1.2× 13 0.2× 10 398
Fu-You Jin United States 6 198 0.8× 211 1.1× 93 0.8× 41 0.5× 11 0.2× 7 346
L.M. Scheek Netherlands 6 194 0.8× 125 0.7× 57 0.5× 62 0.8× 14 0.2× 10 341
MC Cheung United States 6 258 1.1× 220 1.2× 85 0.8× 74 1.0× 13 0.2× 6 403
Olivier Scruel France 11 141 0.6× 142 0.7× 82 0.7× 23 0.3× 21 0.3× 20 311

Countries citing papers authored by L. Perségol

Since Specialization
Citations

This map shows the geographic impact of L. Perségol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Perségol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Perségol more than expected).

Fields of papers citing papers by L. Perségol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Perségol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Perségol. The network helps show where L. Perségol may publish in the future.

Co-authorship network of co-authors of L. Perségol

This figure shows the co-authorship network connecting the top 25 collaborators of L. Perségol. A scholar is included among the top collaborators of L. Perségol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Perségol. L. Perségol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Perségol, L., Maryam Darabi, Marie Lhomme, et al.. (2017). Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate. Journal of Lipid Research. 59(1). 25–34. 25 indexed citations
2.
Perségol, L., Marie‐Claude Brindisi, David Rageot, et al.. (2014). Oxidation-induced loss of the ability of HDL to counteract the inhibitory effect of oxidized LDL on vasorelaxation. Heart and Vessels. 30(6). 845–849. 10 indexed citations
3.
Perségol, L., Laurence Duvillard, Serge Monier, et al.. (2014). No Improvement of High-Density Lipoprotein (HDL) Vasorelaxant Effect Despite Increase in HDL Cholesterol Concentration in Type 2 Diabetic Patients Treated With Glitazones. The Journal of Clinical Endocrinology & Metabolism. 99(10). E2015–E2019. 6 indexed citations
4.
Brindisi, M.-C., et al.. (2013). Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium‐dependent vasorelaxation. Diabetes/Metabolism Research and Reviews. 29(8). 618–623. 9 indexed citations
5.
Brindisi, M.-C., L. Perségol, Laurence Duvillard, & Bruno Vergès. (2009). Rôles des HDL sur l’endothélium. Médecine des Maladies Métaboliques. 3(6). 584–588.
6.
Perségol, L., Matthieu Foissac, Laurent Lagrost, et al.. (2007). HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation. Diabetologia. 50(11). 2384–2387. 45 indexed citations
7.
Perségol, L., Bruno Vergès, Philippe Gambert, & Laurence Duvillard. (2007). Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation. Journal of Lipid Research. 48(6). 1396–1401. 36 indexed citations
8.
Perségol, L., Bruno Vergès, Matthieu Foissac, Philippe Gambert, & Laurence Duvillard. (2006). Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation. Diabetologia. 49(6). 1380–1386. 84 indexed citations
9.
Perségol, L., et al.. (2000). Co-incubation of native and oxidized low-density lipoproteins: potentiation of relaxation impairment. European Journal of Pharmacology. 406(3). 429–437. 8 indexed citations
10.
Desrumaux, Catherine, Anne Athias, Ginette Bessède, et al.. (1999). Mass Concentration of Plasma Phospholipid Transfer Protein in Normolipidemic, Type IIa Hyperlipidemic, Type IIb Hyperlipidemic, and Non–Insulin-Dependent Diabetic Subjects as Measured by a Specific ELISA. Arteriosclerosis Thrombosis and Vascular Biology. 19(2). 266–275. 67 indexed citations
11.
Pont, Frédéric, Laurence Duvillard, Cyrille Maugeais, et al.. (1997). Isotope Ratio Mass Spectrometry, Compared with Conventional Mass Spectrometry in Kinetic Studies at Low and High Enrichment Levels: Application to Lipoprotein Kinetics. Analytical Biochemistry. 248(2). 277–287. 31 indexed citations
12.
Athias, Anne, et al.. (1994). Capillary Gel Electrophoresis Analysis of Apolipoproteins A-I and A-II in Human High-Density Lipoproteins. Analytical Biochemistry. 218(2). 320–324. 18 indexed citations
13.
Lagrost, Laurent, L. Perségol, Christian Lallemant, & Philippe Gambert. (1994). Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII.. Journal of Biological Chemistry. 269(5). 3189–3197. 67 indexed citations
14.
Perségol, L. & R Paris. (1987). Influence of dietary lipids and linoleic acid amounts on fatty acid content and composition of pig serum lipoproteins.. PubMed. 82(1). 36–44. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark S. Borja Breakdown of academic impact, for papers by Valérie Guyard‐Dangremont Breakdown of academic impact, for papers by G. J. Miller Breakdown of academic impact, for papers by Eva Xepapadaki Breakdown of academic impact, for papers by Shiyin Long Breakdown of academic impact, for papers by Gert-Jan Botma Breakdown of academic impact, for papers by Fu-You Jin Breakdown of academic impact, for papers by L.M. Scheek Breakdown of academic impact, for papers by MC Cheung Breakdown of academic impact, for papers by Olivier Scruel
Rankless by CCL
2026